Anzeige
Mehr »
Login
Mittwoch, 08.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Diese Aktie hebt ab: +130,67% Kursgewinn in 1 Monat – das sind die Gründe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
57 Leser
Artikel bewerten:
(0)

Global IVD Market to Reach $78 Billion by 2021 - Shift in Focus from Centralized Labs to Decentralized POC Testing - Research and Markets




DUBLIN, Dec. 14, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "In Vitro Diagnostics/IVD Market by Product, Technology, Application - Forecast to 2021" report to their offering.

The Global IVD Market is projected to reach USD 78.74 Billion by 2021, at a CAGR of 5.5% during the forecast period of 2016 to 2021.

Growth in this market is majorly driven by the increasing prevalence of diseases such as diabetes, cardiovascular diseases, and across the globe and shift in focus from centralized laboratories to decentralized point-of-care testing is also support the growth of the IVD market.

In this report, the global IVD market is segmented by products & services, technology, application, end user, and region. Based on technology, the IVD market is mainly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies.

In 2015, North America commanded the largest share of the IVD market, followed by Europe. The U.S. is a prime market for IVD due to the rising acceptance of point-of-care diagnostics and patient self-testing practices in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers on this region.

Companies Mentioned:

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • Danaher Corporation
  • Diasorin S.P.A.
  • Johnson & Johnson
  • Ortho-Clinical Diagnostics, Inc.
  • Qiagen N.V.
  • Roche Diagnostics
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global IVD Market, by Product & Service

8 Global in Vitro Diagnostics Market, by Technology

9 Global in Vitro Diagnostics Market, by Application

10 Global in Vitro Diagnostics Market, by End User

11 Global in Vitro Diagnostics Market, by Region

12 Competitive Landscape

13 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/kwxmbr/in_vitro

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.